Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 27 May 2024 Article · 29 Nov 2023 Synthesis, Spectral Characterization and Anticancer Study of BioComplexes Pd from Methyl Imidazole
The prepared bio- ligand derived from chalcone -azo (E)-1-(4-(E
Conference abstract · 27 Nov 2023 Comparison of 22C3 PharmDx and SP263 assays to test PD-L1 expression in colorectal cancer patients.
PD-L1 expression, while not a standard companion diagnostic, is a potential predictive biomarker of immunotherapy response in colorectal cancer. There is an unmet need to cross validate commercially-available…
Article · 15 Nov 2023 The Role of pD_L1 expression in bladder cancer
this study is to determine the expression of the PD_L1protein in human bladder cancer, and significant correlations between these parameters and clinico pathologic variables like (grade and stage ... decades alarmingly…
Article · 30 Sep 2023 Neuroprotective Effects of VEM-PD Nasal drops against MPTP- Induced Parkinsonâ??s Disease in Mice
Objective: VEM-PD nasal drops are made of a proprietary herbal blend with micro-emulsions and CNS & PD-beneficial Bio-Actives. Which looked into the potential protective mechanisms ... PD Nasal drops on a mouse model of…
Short communication · 19 Sep 2023 Nanostructured ZnO/Pd-doped ZnO Composites for Energy Devices and Environment Remediation
Nanostructured composites based on Zinc Oxide (ZnO) and Palladium-doped Zinc Oxide (Pd-doped ZnO) have shown significant potential for various energy devices and environmental remediation applications. This paper…
Conference abstract · 18 May 2023 Novel n doped defective ordered mesoporous carbon modified by pd-zn dual-atoms for electrochemical reduction of co2
creatively prepared N doped defective ordered mesoporous carbon (N-CMK-3-D) modified by Pd-Zn dual-atom catalyst for the efficient co2 electro-reduction reaction (CO2RR). By introducing ... migration and agglomeration…
Research article · 25 Apr 2023 Exploring English Language Department Teachers? attitudes towards PD and its challenges at One Saudi Arabian University
study explores how English language teachers at a Saudi Arabian university viewed Professional Development (PD). The research study aims to develop an understanding of the PD these teachers receive ... their views…
Commentary · 17 Mar 2023 Cancer Immune Resistance Before and After Anti-PD Therapy
Mini review · 28 Feb 2023 Parkinson's syndrome (PD) Patients Quality of Life was found to be Significantly Impacted by the Presence of Non-Motor Symptoms
Parkinson’s syndrome (PD) patients’ quality of life was found to be significantly impacted by the presence of non-motor symptoms. This group of symptoms included depression and anxiety, both
Research article · 20 Dec 2022 Correlation between PD-L1 expression, demographic and pathological characters in patients with breast cancer
expression of Programmed Death-Ligand 1 (PD-L1) is associated with immune response evasion in breast cancer, making patients qualified for PD-L1 inhibitors. To better understand the prognostic value ... PD-L1 in breast…
Research article · 23 Nov 2022 Multiomics analysis identifies EBF1 and MYB as key regulators of PD-1 gene in breast cancer
Programmed cell death protein 1 (PD-1), an immune suppressant controls the effector activity of T lymphocytes through interaction with Programmed death-ligand 1 protein (PD-L1). The T cells ... what molecular processes…
Research article · 29 Aug 2022 Skilled Aerobic Exercise Reduces Endoplasmic Reticulum Stress and Dopamine Neuron Apoptosis by Activating Wnt/andbeta;-Catenin Pathway and Improves Motor Function in Pd Model Rats
activating Wnt/β-catenin pathway and improves motor function in Parkinson' s disease (PD) model rats. Methods: The PD models were established by injection into the right SNC (substantia nigra ... apoptosis of DA neurons…
Mini review · 27 Aug 2022 Role of Fc Receptors in Effectiveness and Biodistribution, Prediction of Immunogenicity, Influence on PK/PD of Molecular Properties
cause the emergence of drug resistance and consequently, poorer clinical outcomes. Pharmacokinetic/pharmacodynamics (PK/PD) analysis together with Monte Carlo simulation permits to optimize dosing regimens of the…
Research article · 25 Aug 2022 A Comparative Study of Spin Magnetic Moment, Spin Polarization and Curie Temperature of Heusler Type Compounds (A2-x-y Zy)MnZ (A=Ni, Pd, Pt and Z=Sb, Sn)
Heusler type compounds (A2-x-yZy)MnZ (A=Ni, Pd, Pt; Z=Sb, Sn; x=1, 0; and y=0, antisite defects of Z atoms) are investigated to under-stand
Short communication · 30 Jul 2022 Sensitization of PD-1/L1 Refractory Lung Tumors in an Immunocompetent Mouse Model with AdAPT-001
well-deserved as the the 14/14 complete responses recently reported with the PD-1 inhibitor, dostarlimab, in mismatch repair (MMR) deficient locally advanced rectal cancer demonstrates but comes with ... which encodes…
Research article · 20 Jun 2022 The Effect of Immunomodulator Thymosin andalpha;1 on the Expression of TNBC PD-L1 Through Wnt/andbeta;-Catenin Signaling Pathway
Purpose: Explore whether thymosin affects the expression of PD-L1 on the surface of tumor cells, which in turn affects the immunotherapy of triple-negative breast cancer. Methods: After treating ... human breast cancer…
Research article · 30 Mar 2022 Quality Control of Mitochondria in Parkinson's Disease (PD) Using ATP and Bradford Assays
prominent degeneration of dopaminergic neurons in the substantia nigra. Although the specific pathogenesis involving PD remains under investigation, mitochondrial dysfunction has been widely accepted as one of the major…
Opinion · 28 Mar 2022 Clinical Expression Varies Between Different PD Types
Short communication · 15 Feb 2022 The Predictive Role of Intra-Tumoral CD8+T Cells with Stem Cell-Like Properties in Response to and Efficacy of Anti-PD-1/L1 Treatment
outstanding efficacy in many solid tumors. However, some treated patients with positive expression of PD-L1 do not respond, and even develop hyper progression, and some patients with negative expression ... PD-L1 can…
Short communication · 2022 Neuroinflammation in Parkinson’s disease (PD)

